Objective: To evaluate the outcomes of posterior-chamber phakic intraocular lens (pIOL) implantation in patients with high myopia. Material and Methods: Seventy-six eyes of 38 patients who had high myopia and undergone Eyecrylphakic IOL implantation were enrolled in the study. Eighteen of them (47%) were males and 20 (53%) were females. Their mean age was 28.97±4.10 (22-36) years. Uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), autorefractive and keratometric measurements were evaluated pre and postoperatively. Results: The mean 1st week, 1st month and 6th month postoperative spherical, astigmatic and spherical equivalent (SE) values were significantly lower than those of preoperative values, and the mean 1st week, 1st month and 6th month postoperative UCVA and BCVA values were significantly higher than preoperative values (p0.05). The postoperative first-week mean spherical value was 0.11±0.44 D, and it was stable until the 6th month. Postoperative 6th month mean endothelial cell loss was 3% in comparison with preoperative values. The difference was not significant (p>0.05). Additionally, no abnormal morphologic changes in endothelial cell layer were observed in specular microscopy. Conclusion: Eyecrylphakic IOL implantation is a safe, effective, predictable, and stable treatment method for high-myopia patients in the short-term. Long-term results of pIOL implantation should be investigated in further studies.
Keywords: High myopia; phakic IOL; spherical equivalent; uncorrected visual acuity
Amaç: Yüksek miyopisi olan hastalarda arka kamara fakik intraoküler lens (pIOL) implantasyonunun görsel sonuçlarını değerlendirmek. Gereç ve Yöntemler: Yüksek miyopisi olan ve Eye cryl Fakik IOL implantasyonu uygulanan 38 hastanın 76 gözü çalışma kapsamına alındı. Hastaların 18'i (%47) erkek, 20'si ise (%53) kadındı. Ortalama yaşları 28,97±4,10 (22-36) yıl idi. Düzeltilmemiş görme keskinliği, düzeltilmiş görme keskinliği, otorefraktif ve keratometrik ölçümler ameliyat öncesi ve sonrasında değerlendirildi. Bulgular: Ortalama ameliyat sonrası 1. hafta, 1. ay ve 6. ay sferik, astigmatik ve sferik eşdeğer (SE) ameliyat öncesi değere göre anlamlı olarak daha düşüktü ve ameliyat sonrası düzeltilmemiş ve düzeltilmiş görme keskinliği, ameliyat öncesine göre anlamlı olarak daha yüksekti (p0,05). Ameliyat sonrası 1. hafta ortalama sferik değer 0,11 ± 0,44 D idi ve bu değer 6. aya kadar stabil seyretti. Postoperatif 6. aydaki endotel hücre kaybı %3'tü, preoperatif değere gore anlamlı bir düşüş değildi (p>0,05). Ayrıca, speküler mikroskopide endotel hücre tabakasında anormal morfolojik değişiklikler gözlenmedi. Sonuç: Eyecryl Fakik IOL implantasyonu, yüksek miyopisi olan hastalarda kısa dönemde güvenli, etkin ve ön görülebilir bir tedavi sağlamaktadır. Uzun dönem sonuçları için ileri çalışmaların yapılması gerekir.
Anahtar Kelimeler: Yüksek miyopi; fakik IOL; sferik eşdeğer; düzeltilmemiş görme keskinliği
- Pararajasegaram R. VISION 2020-the right to sight: from strategies to action. Am J Ophthalmol. 1999;128(3):359-60.
- Kempen JH, Mitchell P, Lee KE, Tielsch JM, Broman AT, Taylor HR, et al. The prevalence of refractive errors among adults in the United States, Western Europe, and Australia. Arch Ophthalmol. 2004;122(4):495-505. [Crossref] [PubMed]
- Vitale S, Sperduto RD, Ferris FL. Increased prevalence of myopia in the United States between 1971-1972 and 1999-2004. Arch Ophthalmol. 2009;127(12):1632-9. [Crossref] [PubMed]
- Niroula DR, Saha CG. Study on the refractive errors of school going children of Pokhara city in Nepal. Kathmandu Univ Med J (KUMJ). 2009;7(25):67-72. [Crossref] [PubMed]
- Zheng YF, Pan CW, Chay J, Wong TY, Finkelstein E, Saw SM, et al. The economic cost of myopia in adults aged over 40 years in Singapore. Invest Ophthalmol Vis Sci. 2013;13;54(12):7532-7. [Crossref] [PubMed]
- Smith T, Frick K, Holden B, Fricke T, Naidoo K. Potential lost productivity resulting from the global burden of uncorrected refractive error. Bull World Health Organ. 2009;87(6):431-7. [Crossref] [PubMed] [PMC]
- Cheng D, Schmid KL, Woo GC, Drobe B. Randomized trial of effect of bifocal and prismatic bifocal spectacles on myopic progression: two-year results. Arch Ophthalmol. 2010;128(1):12-9. [Crossref] [PubMed]
- Li SM, Ji YZ, Wu SS, Zhan SY, Wang B, Liu LR, et al. Multifocal versus single vision lenses intervention to slow progression of myopia in school-age children: a meta-analysis. Surv Ophthalmol. 2011;56(5):451-60. [Crossref] [PubMed]
- Reim T, Lund M, Wu R. Orthokeratology and adolescent myopia control. Contact Lens Spectrum. 2003;18:40-2.
- Shih YF, Chen CH, Chou AC, Ho TC, Lin LL, Hung PT, et al. Effects of different concentrations of atropine on controlling myopia in myopic children. J Ocul Pharmacol Ther. 1999;15(1):85-90. [Crossref] [PubMed]
- Rose KA, Morgan IG, Ip J, Kifley A, Huynh S, Smith W, et al. Outdoor activity reduces the prevalence of myopia in children. Ophthalmology. 2008;115(8):1279-85. [Crossref] [PubMed]
- Seiler T, Bende T, Wollensak J, Trokel S. Excimer laser keratectomy for correction of astigmatism. Am J Ophthalmol. 1988;15;105(2):117-24. [Crossref]
- Yang RB, Zhao SZ. AcrySof phakic angle-supported intraocular lens for the correction of high to extremely high myopia: one-year follow-up results. Int J Ophthalmol. 2012;5(3):360-5.
- Güell JL, Morral M, Kook D, Kohnen T. Phakic intraocular lenses part 1: historical overview, current models, selection criteria, and surgical techniques. J Cataract and Refract Surg. 2010;36(11):1976-93. [Crossref] [PubMed]
- Kohnen T, Kook D, Morral M, Güell JL. Phakic intraocular lenses: part 2: results and complications. J Cataract Refract Surg. 2010;36(12):2168-21. [Crossref] [PubMed]
- Tang Y, Ye J. Phakic posterior chamber intraocular lens with a central hole in treating patients with moderate to high myopia: a meta-analysis. J Ophthalmol. 2019;2019:9496326. [Crossref] [PubMed] [PMC]
- Shimizu K, Kamiya K, Igarashi A, Kobashi H. Long-term comparison of posterior chamber phakic ıntraocular lens with and without a central hole (hole ICL and conventional ICL) ımplantation for moderate to high myopia and myopic astigmatism: consort-compliant article. Medicine (Baltimore). 2016;95(14):e3270. [Crossref] [PubMed] [PMC]
- Yaşa D, Ürdem U, Ağca A, Yildirim Y, Kepez Yildiz B, Kandemir Beşek N, et al. Earl results with a new posterior chamber phakic intraocular lens in patients with high myopia. J Ophthalmol. 2018;;2018:1329874. [Crossref] [PubMed] [PMC]
- Moya T, Javaloy J, Montes-Mico R, Beltran J, Munoz G, Montalban R, et al. Implantable collamer lens for myopia: assessment 12 years after implantation. J Refract Surg. 2015;31(8):548-56. [Crossref] [PubMed]
- Pérez-Santonja JJ, Bueno JL, Zato MA. Surgical correction of high myopia in phakic eyes with Worst-Fechner myopia intraocular lenses. J Refract Surg. 1997;13(3):268-81.
- Edelhauser HF, Sanders DR, Azar R, Lamielle H. ICL in Treatment of Myopia Study Group. Corneal endothelial assessment after ICL implantation. J Cataract Refract Surg. 2004;30(3):576-83. [Crossref] [PubMed]
- Galvis V, Villamil JF, Acu-a MF, Camacho PA, Merayo-Lloves J, Tello A, et al. Long-term endothelial cell loss with the iris-claw intraocular phakic lenses (Artisan®). Graefes Arch Clin Exp Ophthalmol. 2019;257(12):2775-87. [Crossref] [PubMed]
- Bohac M, Jagic M, Biscevic A, Shijakova V, Gabric N, Patel S, et al. Changes in endothelial cell count up to three years after implantation of toric implantable collamer lenses. Cornea. 2019;38(7):873-9. [Crossref] [PubMed]
- Bourne WM, Nelson LR, Hodge DO. Central corneal endothelial cell changes over a ten-year period. Invest Ophthalmol Vis Sci. 1997;38(3):779-82.
- Guber I, Mouvet V, Bergin C, Perritaz S, Othenin-Girard P, Majo F, et al. Clinical outcomes and cataract formation rates in eyes 10 years after posterior phakic lens implantation for myopia. JAMA Ophthalmol. 2016;134(5):487-94. [Crossref] [PubMed]
- Navarrete Argüello J, Bello López Portillo H, Cantero Vergara MA, Sierra Acevedo GA, Ruíz Salgado K, Nieto Aguilar MV, et al. [Intraocular pressure fluctuations in patients implanted with an implantable collamer lens (ICL V4c). Three-month follow-up]. Arch Soc Esp Oftalmol. 2019;94(8):367-76. [Crossref]
- Eldanasoury AM, Roozbahani M, Tolees S, Arana C. Long-term effect of anterior chamber depth on endothelial cell density in patients with ıris-fixated phakic ıntraocular lenses. J Refract Surg. 2019;1;35(8):493-500. [Crossref] [PubMed]
- Niu L, Miao H, Han T, Ding L, Wang X, Zhou X, et al. Visual outcomes of Visian ICL implantation for high myopia in patients with shallow anterior chamber depth. BMC Ophthalmol. 2019;29;19(1):121. [Crossref] [PubMed] [PMC]
- Sachdev GS, Singh S, Rajpal N, Dandapani R. Comparative analysis of clinical outcomes between two types of posterior chamber phakic intraocular lenses for correction of myopia and myopic astigmatism. Indian J Ophthalmol. 2019;67(7):1061-5. [Crossref] [PubMed] [PMC]
- Qin Q, Wu Z, Bao L, Chen H, Yang L, He Z, et al. Evaluation of visual quality after EVO-ICL implantation for hypermyopia: an observational study. Medicine (Baltimore). 2019;98(44):e17677. [Crossref] [PubMed] [PMC]
- Choi JH, Lim DH, Nam SW, Yang CM, Chung ES, Chung TY, et al. Ten-year clinical outcomes after implantation of a posterior chamber phakic intraocular lens for myopia. J Cataract Refract Surg. 2019;45(11):1555-61. [Crossref] [PubMed]
.: Process List